Time to petition for a rehearing, or a rehearing En Banc in the federal Court of Appeals, has not run out yet. Rules 35 and 40 of the Federal Rules of Appellate Procedure set that time period to be within 14 days of the entry of judgment for regular parties, but within 45 days if the "United States or its officer or agency" is a party, as of course the FDA is, unless the Court itself issues an order shortening or extending the time.
Federal Rules of Appellate Procedure
Time to petition to the US Supreme Court for a Writ of Certiorari (permission to appeal essentially) is within 90 days (and that would actually be after any petition for rehearing, if submitted, is denied).
SUPREME COURT RULES - Rule 13
Edit to add a PS: The Order that the Clerk "withhold issuance of the mandate herein until seven days after disposition of any timely petition for rehearing or petition for rehearing en banc" was simply routine, allowing the losing party time to decide whether to file further petitions before jurisdiction is handed back to the District Court. And that order itself was subject to any party's right "to move for expedited issuance of the mandate for good cause shown". The "mandate" is simply the Court's formal issuance of its judgment on appeal, and the case cannot be further acted on by the court below until it is issued. See, Rule 41, Federal Rules cited above.
For example, here is a case where a party is moving for expedited issuance of the mandate, after winning against the FDA. http://www.fdalawblog.net/files/losartan---teva-emerg-mandate-motion.pdf
Federal Rules of Appellate Procedure
Time to petition to the US Supreme Court for a Writ of Certiorari (permission to appeal essentially) is within 90 days (and that would actually be after any petition for rehearing, if submitted, is denied).
SUPREME COURT RULES - Rule 13
Edit to add a PS: The Order that the Clerk "withhold issuance of the mandate herein until seven days after disposition of any timely petition for rehearing or petition for rehearing en banc" was simply routine, allowing the losing party time to decide whether to file further petitions before jurisdiction is handed back to the District Court. And that order itself was subject to any party's right "to move for expedited issuance of the mandate for good cause shown". The "mandate" is simply the Court's formal issuance of its judgment on appeal, and the case cannot be further acted on by the court below until it is issued. See, Rule 41, Federal Rules cited above.
For example, here is a case where a party is moving for expedited issuance of the mandate, after winning against the FDA. http://www.fdalawblog.net/files/losartan---teva-emerg-mandate-motion.pdf
Last edited:
.